Stocktoria
Zentalis Pharmaceuticals, Inc. ZNTL
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-04-03
Zentalis Pharmaceuticals, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 4,818,546 | $19.7M |
| TWO SIGMA INVESTMENTS, LP | 2,956,526 | $6.9M |
| RENAISSANCE TECHNOLOGIES LLC | 1,938,145 | $4.5M |
| CITADEL ADVISORS LLC | 1,756,283 | $4.1M |
| D. E. Shaw & Co., Inc. | 1,484,098 | $3.5M |
| MILLENNIUM MANAGEMENT LLC | 1,289,822 | $3.0M |
| Point72 Asset Management, L.P. | 94,854 | $221,958 |
| AQR CAPITAL MANAGEMENT LLC | 22,675 | $53,059 |
Source: SEC EDGAR filings · CIK 0001725160 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.